Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).
(2015) In Primary Care Diabetes 9(1). p.15-22- Abstract
- Patients with type 2 diabetes are generally treated in primary care setting and as a final treatment step to obtain good glycaemic control, multiple daily insulin injections (MDI) are generally used. The aim of this study is to evaluate the effect of GLP-1 analogue liraglutide on glycaemic control in patients with type 2 diabetes treated with MDI with inadequate glycaemic control.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4692808
- author
- Lind, Marcus ; Hirsch, Irl B ; Tuomilehto, Jaakko ; Dahlqvist, Sofia ; Torffvit, Ole LU and Pehrsson, Nils-Gunnar
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Primary Care Diabetes
- volume
- 9
- issue
- 1
- pages
- 15 - 22
- publisher
- Elsevier
- external identifiers
-
- pmid:25175385
- wos:000348265500003
- scopus:84920614644
- pmid:25175385
- ISSN
- 1878-0210
- DOI
- 10.1016/j.pcd.2014.07.010
- language
- English
- LU publication?
- yes
- id
- 56f58f5b-f09d-4e8e-a6d8-288a4c63a4d7 (old id 4692808)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25175385?dopt=Abstract
- date added to LUP
- 2016-04-01 10:09:26
- date last changed
- 2022-04-27 19:10:07
@article{56f58f5b-f09d-4e8e-a6d8-288a4c63a4d7, abstract = {{Patients with type 2 diabetes are generally treated in primary care setting and as a final treatment step to obtain good glycaemic control, multiple daily insulin injections (MDI) are generally used. The aim of this study is to evaluate the effect of GLP-1 analogue liraglutide on glycaemic control in patients with type 2 diabetes treated with MDI with inadequate glycaemic control.}}, author = {{Lind, Marcus and Hirsch, Irl B and Tuomilehto, Jaakko and Dahlqvist, Sofia and Torffvit, Ole and Pehrsson, Nils-Gunnar}}, issn = {{1878-0210}}, language = {{eng}}, number = {{1}}, pages = {{15--22}}, publisher = {{Elsevier}}, series = {{Primary Care Diabetes}}, title = {{Design and methods of a randomised double-blind trial of adding liraglutide to control HbA1c in patients with type 2 diabetes with impaired glycaemic control treated with multiple daily insulin injections (MDI-Liraglutide trial).}}, url = {{http://dx.doi.org/10.1016/j.pcd.2014.07.010}}, doi = {{10.1016/j.pcd.2014.07.010}}, volume = {{9}}, year = {{2015}}, }